Peptide Antimicrobial Agents
Open accessThe DOI matches its Crossref record; 256 of the 256 references it cites were found in a registry or an index.
Abstract
SUMMARY: Antimicrobial host defense peptides are produced by all complex organisms as well as some microbes and have diverse and complex antimicrobial activities. Collectively these peptides demonstrate a broad range of antiviral and antibacterial activities and modes of action, and it is important to distinguish between direct microbicidal and indirect activities against such pathogens. The structural requirements of peptides for antiviral and antibacterial activities are evaluated in light of the diverse set of primary and secondary structures described for host defense peptides. Peptides with antifungal and antiparasitic activities are discussed in less detail, although the broad-spectrum activities of such peptides indicate that they are important host defense molecules. Knowledge regarding the relationship between peptide structure and function as well as their mechanism of action is being applied in the design of antimicrobial peptide variants as potential novel therapeutic agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, several AMPs can modulate immune and inflammatory responses, inducing phagocytosis, promotion of immune cell recruitment, regulation of angiogenesis, and stimulation of prostaglandin release (13, 19, 20, 25–29)”
From On the Role of NMR Spectroscopy for Characterization of Antimicrobial Peptides (2013) · cites this paper as [13]
In the citing paper
“These two models share some similarities and involve four major steps: attraction, attachment, insertion, and membrane permeation (13, 50).”
From On the Role of NMR Spectroscopy for Characterization of Antimicrobial Peptides (2013) · cites this paper as [13]
In the citing paper
“AMPs are usually cationic, relatively short (less than a hundred amino acid residues), and amphipathic, with approximately half of the residues hydrophobic so as to enable their associations with cell membranes (13, 46–54)”
From On the Role of NMR Spectroscopy for Characterization of Antimicrobial Peptides (2013) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–256 of 256
McCann, K. B., Lee, A., Wan, J., Roginski, H., & Coventry, M. J. (2003) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.2003.02071.x · Cited by 88
Interaction of Polylysine with the Cellular Receptor for Herpes Simplex Virus Type 1
Langeland, N., Moore, L. J., Holmsen, H., & Haarr, L. (1988) · Journal of General Virology · doi:10.1099/0022-1317-69-6-1137 · Cited by 84
Giles, F. J., Rodríguez, R., Weisdorf, D. J., Wingard, J. R., Martin, P. J., Fleming, T. R., Goldberg, S. L., Anaissie, E. J., Bolwell, B. J., Chao, N. J. A., et al. (2003) · Leukemia Research · doi:10.1016/j.leukres.2003.10.021 · Cited by 83
Houston, M. E., Kondejewski, L. H., Karunaratne, D. N., Gough, M., Fidai, S., Hodges, R. S., & Hancock, R. E. W. (1998) · Journal of Peptide Research · doi:10.1111/j.1399-3011.1998.tb01361.x · Cited by 83
Self-citationFaber, C., Stallmann, H. P., Lyaruu, D. M., Joosten, U., von Eiff, C., Amerongen, A. V. N., & Wuisman, P. I. J. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2438-2444.2005 · Cited by 81
Kim, D., Lee, D. G., Kim, K. L., & Lee, Y. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02364.x · Cited by 80
Zelezetsky, I., Pag, U., Sahl, H., & Tossi, A. (2005) · Peptides · doi:10.1016/j.peptides.2005.05.002 · Cited by 79
Fungicidal and binding properties of the natural peptides cecropin B and dermaseptin
Lucca, A. J. D., Bland, J. M., Jacks, T. J., Grimm, C. C., & Walsh, T. J. (1998) · Medical Mycology · doi:10.1080/02681219880000461 · Cited by 79
Lookene, A., Savonen, R., & Olivecrona, G. (1997) · Biochemistry · doi:10.1021/bi962699k · Cited by 77
Properties of a Heparin-binding Peptide Derived from Bovine Lactoferrin
Shimazaki, K., Tazume, T., Uji, K., Tanaka, M., Kumura, H., Mikawa, K., & Shimo‐Oka, T. (1998) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(98)75843-6 · Cited by 77
Identification of an import signal for, and the nuclear localization of, human lactoferrin
Penco, S., Scarfi, S., Giovine, M., Damonte, G., Millo, E., Villaggio, B., Passalacqua, M., Pozzolini, M., Garrè, C., & Benatti, U. (2001) · Biotechnology and Applied Biochemistry · doi:10.1042/ba20010038 · Cited by 76
Differential expression of α‐ and β‐defensins in human peripheral blood
Fang, X., Shu, Q., Chen, Q., Book, M., Sahl, H., Hoeft, A., & Stüber, F. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01076.x · Cited by 75
VEERMAN, E. C. I., NAZMI, K., van 't HOF, W., BOLSCHER, J. G. M., den HERTOG, A. L., & NIEUW AMERONGEN, A. V. (2004) · Biochemical Journal · doi:10.1042/bj20040208 · Cited by 75
Barbault, F., Landon, C., Guenneugues, M., Meyer, J.-P., Schott, V., Dimarcq, J., & Vovelle, F. (2003) · Biochemistry · doi:10.1021/bi035400o · Cited by 75
Inhibitory Effect of Tachyplesin I on the Proliferation of Human Immunodeficiency Virus in vitro
Morimoto, M., Mori, H., Otake, T., Noboru, U. E. B. A., Kunita, N., Niwa, M., Murakami, T., & Iwanaga, S. (2009) · Chemotherapy · doi:10.1159/000238855 · Cited by 75
Antiviral activity of ovotransferrin derived peptides
Giansanti, F., Massucci, M. T., Giardi, M. F., Nozza, F., Pulsinelli, E., Nicolini, C. A., Botti, D., & Antonini, G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.125 · Cited by 73
Yang, N., Strøm, M. B., Mekonnen, S. M., Svendsen, J. S. M., & Rekdal, Ø. (2003) · Journal of Peptide Science · doi:10.1002/psc.470 · Cited by 69
Activity of Protegrins against Yeast-Phase Candida albicans
Cho, Y., Turner, J. S., Dinh, N.-N., & Lehrer, R. I. (1998) · Infection and Immunity · doi:10.1128/iai.66.6.2486-2493.1998 · Cited by 69
Role of Positional Hydrophobicity in the Leishmanicidal Activity of Magainin 2
Guerrero, E., Saugar, J. M., Matsuzaki, K., & Rivas, L. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.2980-2986.2004 · Cited by 68
Human milk lactoferrin binds two DNA molecules with different affinities
Kanyshkova, T. G., Semenov, D. V., Buneva, V. N., & Nevinsky, G. A. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00579-7 · Cited by 65
Different Anti- Candida Activities of Two Human Lactoferrin-Derived Peptides, Lfpep and Kaliocin-1
Viejo-Díaz, M., Andrés, M. T., & Fierro, J. F. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2583-2588.2005 · Cited by 63
Pn-AMP1, a Plant Defense Protein, Induces Actin Depolarization in Yeasts
Koo, J. C., Lee, B., Young, M. E., Koo, S. C., Cooper, J. A., Baek, D., Lim, C. O., Lee, S. Y., Yun, D.-J., & Cho, M. J. (2004) · Plant and Cell Physiology · doi:10.1093/pcp/pch189 · Cited by 62
FUJIMURA, M., IDEGUCHI, M., Minami, Y., Watanabe, K., & Tadera, K. (2004) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.68.571 · Cited by 61
Lupetti, A., Paulusma-Annema, A., Senesi, S., Campa, M., van Dissel, J. T., & Nibbering, P. H. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1634-1639.2002 · Cited by 60
Anti-endotoxin properties of cationic host defence peptides and proteins
Bowdish, D. M. E., & Hancock, R. E. W. (2005) · Journal of Endotoxin Research · doi:10.1179/096805105x37394 · Cited by 59
Self-citationJenssen, H., Andersen, J. H., MANTZILAS, D., & GUTTEBERG, T. (2004) · Antiviral Research · doi:10.1016/j.antiviral.2004.08.003 · Cited by 59
Self-citationRoch, P. G., Beschin, A., & Bernard, É. (2004) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/neh033 · Cited by 58
The big and small of drug discovery
Moore, A. (2003) · EMBO Reports · doi:10.1038/sj.embor.embor748 · Cited by 54
Park, Y., Jang, S., Lee, D. G., & Hahm, K. (2003) · Journal of Peptide Science · doi:10.1002/psc.518 · Cited by 54
Brief overview on cellular virus receptors
Mettenleiter, T. C. (2001) · Virus Research · doi:10.1016/s0168-1702(01)00380-x · Cited by 52
Structural and Functional Analysis of Horse Cathelicidin Peptides
Skerlavaj, B., Scocchi, M., Gennaro, R., Risso, A., & Zanetti, M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.715-722.2001 · Cited by 52
Lee, D. G., Kim, P. I., Park, Y., Woo, E., Choi, J. S., Choi, C.-H., & Hahm, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00222-x · Cited by 51
Bovine lactoferrin peptidic fragments involved in inhibition of Echovirus 6 in vitro infection
Pietrantoni, A., Ammendolia, M. G., Tinari, A., Siciliano, R. A., Valenti, P., & Superti, F. (2005) · Antiviral Research · doi:10.1016/j.antiviral.2005.10.006 · Cited by 50
Xu, Y., Tamamura, H., Arakaki, R., Nakashima, H., Zhang, X., Fujii, N., Uchiyama, T., & Hattori, T. (1999) · AIDS Research and Human Retroviruses · doi:10.1089/088922299311169 · Cited by 48
Lee, D. G., Kim, D., Park, Y., Kim, H. K., Kim, H. N., Shin, Y. K., Choi, C. H., & Hahm, K. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4602 · Cited by 48
Synthesis and HIV-1 integrase inhibitory activity of dimeric and tetrameric analogs of indolicidin
Krajewski, K., Marchand, C., Long, Y., Pommier, Y. G., & Roller, P. P. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.08.061 · Cited by 47
Lee, P. H. A., Rudisill, J. A., Lin, K. H., Zhang, L., Harris, S. M., Falla, T. J., & Gallo, R. L. (2004) · Wound Repair and Regeneration · doi:10.1111/j.1067-1927.2004.012303.x · Cited by 46
In vitro and in vivo antibacterial activity of cefoperazone.
Mitsuhashi, S., Minami, S., Matsubara, N., Yotsuji, A., Kurashige, S., & Saikawa, I. (1980) · PubMed · Cited by 44
Parker, K. H., Winlove, C. P., & Maroudas, A. (1988) · Biophysical Chemistry · doi:10.1016/0301-4622(88)87013-3 · Cited by 42
Lee, D. G., Hahm, K., & Shin, S. Y. (2004) · Biotechnology Letters · doi:10.1023/b:bile.0000015472.09542.6d · Cited by 41
Nagaoka, I., Kuwahara‐Arai, K., Tamura, H., Hiramatsu, K., & Hirata, M. (2005) · Inflammation Research · doi:10.1007/s00011-004-1323-8 · Cited by 39
Structure–antiviral activity relationships of cecropin A‐magainin 2 hybrid peptide and its analogues
Lee, D. G., Park, Y., Jin, I., Hahm, K., Lee, H., Moon, Y., & Woo, E. (2003) · Journal of Peptide Science · doi:10.1002/psc.504 · Cited by 39
Song, B. H., Lee, G. C., Moon, M. S., Cho, Y. H., & Lee, C. H. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-10-2405 · Cited by 38
Hurt‐Camejo, E., Rosengren, B. E., Camejo, G., Sartipy, P., Fager, G., & Bondjers, G. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.9.1456 · Cited by 38
Interaction of an Anti-HIV Peptide, T22, with GP120 and CD4
Tamamura, H., Otaka, A., Murakami, T., Ishihara, T., Ibuka, T., Waki, M., Matsumoto, A., Yamamoto, N., & Fujii, N. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0272 · Cited by 37
Ösapay, K., Tran, D., Ladokhin, A. S., White, S. H., Henschen, A. H., & Selsted, M. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.12017 · Cited by 37
Fungicidal and binding properties of the natural peptides cecropin B and dermaseptin
LUCCA, D., Bland, J. M., JACKS, GRIMM, & WALSH (1998) · Medical Mycology · doi:10.1046/j.1365-280x.1998.00160.x · Cited by 37
Park, Y., Lee, D. G., & Hahm, K. (2003) · Journal of Peptide Science · doi:10.1002/psc.489 · Cited by 32
Modelling of anti‐HSV activity of lactoferricin analogues using amino acid descriptors
Jenssen, H., Gutteberg, T. J., & Lejon, T. (2004) · Journal of Peptide Science · doi:10.1002/psc.604 · Cited by 32
Self-citationThree-Dimensional Structure of RK-1: A Novel α-Defensin Peptide
McManus, A. M., Dawson, N. F., Wade, J. D., Carrington, L. E., Winzor, D., & Craik, D. J. (2000) · Biochemistry · doi:10.1021/bi000457l · Cited by 31
Pérez, A., Li, Q.-X., Pérez‐Romero, P., DeLassus, G. S., Lopez, S. R., Sutter, S. B., McLaren, N. C., & Fuller, A. O. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7419-7430.2005 · Cited by 31
Fu, H., Björstad, Å., Dahlgren, C., & Bylund, J. (2004) · Inflammation · doi:10.1007/s10753-004-6644-9 · Cited by 25
Trybala, E., Olofsson, S., Mårdberg, K., Svennerholm, B., Umemoto, K., Glorioso, J. C., & Bergström, T. B. (2004) · Antiviral Research · doi:10.1016/j.antiviral.2003.12.007 · Cited by 21
Pérez‐Romero, P., & Fuller, A. O. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7431-7437.2005 · Cited by 15
PAPILLOMAVIRUS BINDING AND ENTRY The heparan sulfate receptor and inhibition by lactoferrin
Drobni, P. (2005) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 1
Shaping animal body plans in development and evolution by modulation of Hox expression patterns
(1998) · doi:10.1002/(sici)1521-1878(199802)20:2
Cited by
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
Hancock, R. E. W., & Sahl, H.-G. (2006) · Nature Biotechnology · doi:10.1038/nbt1267 · Cited by 4,208
Self-citationNanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
Huang, Y., Ren, J., & Qu, X. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00672 · Cited by 3,523
Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
Mahlapuu, M., Håkansson, J., Ringstad, L., & Björn, C. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00194 · Cited by 1,927
Endosomal escape pathways for delivery of biologicals
Varkouhi, A. K., Scholte, M., Storm, G., & Haisma, H. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.004 · Cited by 1,561
“Formation of toroidal pore model is mediated by aggregates of peptides which enter into the membrane in a perpendicular orientation followed by membrane curving inward to form a hole which the peptides line it [32].”
BackgroundAntimicrobial host defence peptides: functions and clinical potential
Mookherjee, N., Anderson, M. A., Haagsman, H. P., & Davidson, D. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0058-8 · Cited by 1,502
Metadata
- Authors
- Jenssen, H., Hamill, P., & Hancock, R. E. W.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2006-07
- Volume
- 19
- Issue
- 3
- Pages
- 491-511
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2159861471
- Cited by
- 2,518
- References
- 256
- FWCI
- 62.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.